These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22229549)

  • 1. Impact of lipophilic efficiency on compound quality.
    Tarcsay A; Nyíri K; Keseru GM
    J Med Chem; 2012 Feb; 55(3):1252-60. PubMed ID: 22229549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the influence of molecular topology on ligand binding.
    Oka R; Engkvist O; Chen H
    J Mol Graph Model; 2013 Mar; 40():22-9. PubMed ID: 23353581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations.
    Shultz MD
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5992-6000. PubMed ID: 24054120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of lipophilicity in drug discovery and design.
    Arnott JA; Planey SL
    Expert Opin Drug Discov; 2012 Oct; 7(10):863-75. PubMed ID: 22992175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space.
    Meanwell NA
    Chem Res Toxicol; 2016 Apr; 29(4):564-616. PubMed ID: 26974882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How are fragments optimized? A retrospective analysis of 145 fragment optimizations.
    Ferenczy GG; Keserű GM
    J Med Chem; 2013 Mar; 56(6):2478-86. PubMed ID: 23437770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in physicochemical and ADMET profiling in drug discovery.
    Wang J; Skolnik S
    Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of triazolopyrimidine-based PDE8B inhibitors: exceptionally ligand-efficient and lipophilic ligand-efficient compounds for the treatment of diabetes.
    DeNinno MP; Wright SW; Etienne JB; Olson TV; Rocke BN; Corbett JW; Kung DW; DiRico KJ; Andrews KM; Millham ML; Parker JC; Esler W; van Volkenburg M; Boyer DD; Houseknecht KL; Doran SD
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5721-6. PubMed ID: 22858141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of high-throughput ADME in drug discovery.
    Kassel DB
    Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ligand efficiency metrics in drug discovery.
    Hopkins AL; Keserü GM; Leeson PD; Rees DC; Reynolds CH
    Nat Rev Drug Discov; 2014 Feb; 13(2):105-21. PubMed ID: 24481311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States.
    Stepan AF; Walker DP; Bauman J; Price DA; Baillie TA; Kalgutkar AS; Aleo MD
    Chem Res Toxicol; 2011 Sep; 24(9):1345-410. PubMed ID: 21702456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular inflation, attrition and the rule of five.
    Leeson PD
    Adv Drug Deliv Rev; 2016 Jun; 101():22-33. PubMed ID: 26836397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relating molecular properties and in vitro assay results to in vivo drug disposition and toxicity outcomes.
    Sutherland JJ; Raymond JW; Stevens JL; Baker TK; Watson DE
    J Med Chem; 2012 Jul; 55(14):6455-66. PubMed ID: 22716080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical property profile for brain permeability: comparative study by different approaches.
    Raevsky OA; Grigorev VY; Polianczyk DE; Sandakov GI; Solodova SL; Yarkov AV; Bachurin SO; Dearden JC
    J Drug Target; 2016 Aug; 24(7):655-62. PubMed ID: 26755431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    Talevi A; Goodarzi M; Ortiz EV; Duchowicz PR; Bellera CL; Pesce G; Castro EA; Bruno-Blanch LE
    Eur J Med Chem; 2011 Jan; 46(1):218-28. PubMed ID: 21112128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamics guided lead discovery and optimization.
    Ferenczy GG; Keserũ GM
    Drug Discov Today; 2010 Nov; 15(21-22):919-32. PubMed ID: 20801227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing compound and project progress through multi-objective-based compound quality assessment.
    Nissink JW; Degorce S
    Future Med Chem; 2013 May; 5(7):753-67. PubMed ID: 23651090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Strategy of molecular drug design: hits, leads and drug candidates].
    Guo ZR
    Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.